Meij Johanna T A, Carlson Eric C, Wang Li, Liu Chia-Yang, Jester James V, Birk David E, Kao Winston W Y
Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
Mol Vis. 2007 Oct 18;13:2012-8.
To investigate whether targeted expression of lumican in the mouse cornea rescued the Lum(-/-) phenotype.
Lum(-/-)/Kera-Lum mice were generated by crossing Lum(-/-) mice with Kera-Lum transgenic mice that overexpressed lumican under the control of the keratocan promoter. Mouse eyes were analyzed in vivo by confocal microscopy through focusing (CMTF) to determine corneal sublayer thickness and haze. Subsequently, one cornea from each mouse was processed for SDS-PAGE/western blotting while the other was used for either electron microscopy (EM) or real-time polymerase chain reaction (RT-PCR).
Overall, corneas of Lum(-/-)/Kera-Lum mice showed significant improvement over Lum(-/-) but were still deficient when compared to wildtype (WT) mice. Specifically, analysis of Lum(-/-)/Kera-Lum mouse eyes by CMTF showed a similar stromal but slightly increased epithelial thickness compared to matching Lum(-/-) mice. Analysis of the CMTF scans for light backscattering revealed a small yet significant reduction in corneal haze in Lum(-/-)/Kera-Lum mice as compared to Lum(-/-) mice. At the EM level, the pronounced disarray of the posterior fibrillar matrix seen in Lum(-/-) mice was not observed in Lum(-/-)/Kera-Lum mice. Moreover, analyses of collagen fibril diameter distributions showed a significant reduction in the number of large-diameter (>40 nm) fibrils in Lum(-/-)/Kera-Lum mice as compared to Lum(-/-) mice. No significant differences in keratocan expression were found at the mRNA level, but western blot analysis detected an approximately twofold increase in keratocan protein levels in Lum(-/-)/Kera-Lum over Lum(-/-) mice.
Together these data suggest that despite the low keratocan promoter activity driving the transgene in Lum(-/-) cornea, transgenic lumican expression was sufficient to partially rescue corneal phenotypic deficiencies.
研究在小鼠角膜中靶向表达核心蛋白聚糖是否能挽救Lum(-/-)表型。
通过将Lum(-/-)小鼠与在角膜蛋白聚糖启动子控制下过表达核心蛋白聚糖的Kera-Lum转基因小鼠杂交,产生Lum(-/-)/Kera-Lum小鼠。通过聚焦共聚焦显微镜(CMTF)对小鼠眼睛进行体内分析,以确定角膜亚层厚度和混浊度。随后,将每只小鼠的一只角膜用于SDS-PAGE/蛋白质免疫印迹分析,另一只用于电子显微镜(EM)或实时聚合酶链反应(RT-PCR)。
总体而言,Lum(-/-)/Kera-Lum小鼠的角膜与Lum(-/-)小鼠相比有显著改善,但与野生型(WT)小鼠相比仍有缺陷。具体而言,通过CMTF对Lum(-/-)/Kera-Lum小鼠眼睛进行分析,与匹配的Lum(-/-)小鼠相比,其基质厚度相似,但上皮厚度略有增加。对CMTF扫描的光背散射分析显示,与Lum(-/-)小鼠相比,Lum(-/-)/Kera-Lum小鼠的角膜混浊度有小幅但显著的降低。在电子显微镜水平上,未在Lum(-/-)/Kera-Lum小鼠中观察到Lum(-/-)小鼠中所见的后纤维基质的明显紊乱。此外,胶原纤维直径分布分析显示,与Lum(-/-)小鼠相比,Lum(-/-)/Kera-Lum小鼠中直径大于40nm的大直径纤维数量显著减少。在mRNA水平上未发现角膜蛋白聚糖表达有显著差异,但蛋白质免疫印迹分析检测到Lum(-/-)/Kera-Lum小鼠中角膜蛋白聚糖蛋白水平比Lum(-/-)小鼠增加了约两倍。
这些数据共同表明,尽管在Lum(-/-)角膜中驱动转基因的角膜蛋白聚糖启动子活性较低,但转基因核心蛋白聚糖的表达足以部分挽救角膜表型缺陷。